Skip to main content

Gaithersburg’s OpGen to combine with German molecular diagnostic company

The transaction is expected to close by early 2020 once both companies’ shareholders approve it.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.